Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The combined epidermal growth factor‐like modules of Plasmodium yoelii Merozoite Surface Protein‐1 are required for a protective immune response to the parasiteParasite Immunology, 1995
- Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.Journal of Experimental Medicine, 1994
- The major merozoite surface protein as a malaria vaccine targetParasitology Today, 1993
- Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1Molecular and Biochemical Parasitology, 1992
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.Journal of Experimental Medicine, 1990
- Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoeliiMolecular and Biochemical Parasitology, 1989
- Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coliParasite Immunology, 1988
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988
- Inbred mice infected with Plasmodium yoelii differ in their antimalarial immunoglobulin isotype responseParasite Immunology, 1988
- Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvantParasite Immunology, 1986